Bispecific Focus iQ has emphasis on bispecific antibody programs and T cell based assays, creating an opportunity to position iQ as the go to partner for early stage bispecific development, offering tailored in vitro assays, functional readouts, and safety validation.

End to End CRO With capabilities spanning in vitro safety assays, functional characterization, and in vivo pharmacology, iQ can offer integrated preclinical packages that attract small biotech and academic customers moving from discovery to preclinical validation.

Agile Partnering A lean mid sized team enables high touch flexible collaborations and rapid turnarounds, an appealing value prop for resource constrained startups and university partners seeking customizable outsourcing.

Bay Area Access Based in Alameda within the SF Bay biotechnology corridor, iQ can cultivate partnerships with nearby startups, university labs, and venture backed companies for ongoing biospecimen provisioning and assay development support.

Differentiated Service iQ size and specialized focus present an opportunity to secure long term preferred vendor relationships by differentiating on personalized service, rapid communication, and bespoke assay development for niche programs like bispecifics.